title: [Human papillomavirus vaccine. Statement of the Advisory Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008].
abstract: This article briefly reviews the epidemiology of human papillomavirus (HPV) infection and associated diseases globally and in Chile, and the scientific information of the licensed HPV vaccines: Gardasil and Cervari. Considering the available information, the Advisory Committee on Immunizations of the Chilean Society of Infectious Diseases recommends vaccination of teenage girls, ideally before initiating sexual activity, i.e., approximately at the age of 12 to 13 years and vaccination of women of any age if they have not started sexual activity. If women are vaccinated after initiating sexual activity, they should be informed of the lower efficacy of immunization if HPV infection has occurred. Education on responsible sexuality and sexually transmitted diseases should be maintained as a priority. Vaccination should be highly considered for inclusion in the National Immunization Program.
authors.affiliation: Departamento de Pediatria, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago. katia@med.puc.cl
authors.forename: Katia
authors.initials: K
authors.lastname: Abarca
authors.forename: M Teresa
authors.initials: MT
authors.lastname: Valenzuela
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Vergara
authors.forename: Vivian
authors.initials: V
authors.lastname: Luchsinger
authors.forename: Alma
authors.initials: A
authors.lastname: Muñoz
authors.forename: Jorge
authors.initials: J
authors.lastname: Jiménez de la J
authors.forename: Erna
authors.initials: E
authors.lastname: Ripoll
authors.forename: Miguel
authors.initials: M
authors.lastname: O'Ryan
mesh_terms: D000293:Adolescent; D000328:Adult; D026683:Advisory Committees; D002648:Child; D002677:Chile / Q000453:epidemiology; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D007114:Immunization; D008297:Male; D008875:Middle Aged; D027383:Papillomaviridae / Q000145:classification / Q000235:genetics / Q000276:immunology; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000009:adverse effects / Q000276:immunology; D012955:Societies, Medical; D055815:Young Adult
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18